Conversion of ERalpha cells to ERbeta cells in a cell lineage
Conversion of ERalpha cells to ERbeta cells in a cell lineage
批准号:
9756432
负责人:
CHEMYONG JAY KO
金额:
$19.83万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-06 至 2021-07-31
关键词:
Cell LineageCellsDNA Sequence AlterationDevelopmentESR1 geneESR2 geneEmbryoEnterobacteria phage P1 Cre recombinaseEpigenetic ProcessEpitheliumEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogen ReceptorsEstrogensExposure toFOXL2 geneGonadal RidgeGonadal Steroid HormonesInfertilityInvestigationKnock-outLaboratoriesLeadLocationLongevityMalignant neoplasm of prostateMesonephric structureMethodsMethylationModificationMolecularMusMutant Strains MiceOocytesOrganOvarianOvaryPathologicPhenotypePhysiologicalPrimordial FollicleReceptor GeneRegulatory ElementReporter GenesRoleSurfaceTestingTissuesTransgenic MiceTransgenic Organismscell typedesignendometriosisepigenetic regulationfascinatefetalgranulosa cellimprovedinnovationmalignant breast neoplasmnoveloutcome forecastpromoterreceptorreproductive functionreproductive organresponsetheca celltoxicant
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
This study aims to test the hypothesis that an ESR1-expressing cell can be converted to an ESR2-expressing
cell and investigate the molecular mechanism that controls the switch. 17β−estradiol (E2) is the key sex
hormone regulating development and function of reproductive organs. While two estrogen receptors, ESR1
and ESR2, are well known to be responsible for the classical actions of E2, recent investigations into the
functional role of ESR2 show that E2 elicits physiological responses from ESR2-expressing cells that are often
completely opposite to those from ESR1-expressing cells. Importantly, while ESR1- and ESR2-expressing
cells are co-existent in most of estrogen-responsive organs or tissues, ESR1 and ESR2 are expressed in
different cell types. For example, ESR1 is expressed in the surface epithelium and theca cells in the ovary,
whereas ESR2 is expressed exclusively in the granulosa cells (GC). No ovarian cell expresses both receptors.
We recently made an unexpected observation during a characterization of a transgenic mouse line
(Esr1iCreEsr2flox/flox) in which the Esr2 gene was designed to be ablated by a Cre recombinase whose
expression was regulated by the endogenous Esr1 gene promoter. In other words, in this transgenic mouse
line, the Esr2 gene was deleted in the ESR1 lineage cells. Surprisingly, we found that these transgenic mice
were completely deficient of ESR2 expression in the granulosa cells, which otherwise express ESR2
abundantly. This finding indicates that GC lineage cells express ESR1 for some period prior to beginning to
express ESR2, evidence of a conversion of ESR1 to ESR2 in the GC lineage. In this study, we will determine
exactly when the ESR1 to ESR2 conversion occurs and what underlying mechanism controls the ESR1 and
ESR2 expression, using novel transgenic mouse lines that the PI's laboratory generated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelin-2 in Ovarian Follicle Rupture
-
批准号:7572871
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2006
-
负责人:CHEMYONG JAY KO
-
依托单位:
Endothelin-2 in Ovarian Follicle Rupture
-
批准号:7232265
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2006
-
负责人:CHEMYONG JAY KO
-
依托单位:
Endothelin-2 in Ovarian Follicle Rupture
-
批准号:7077104
-
项目类别:
-
资助金额:$24.31万
-
财政年份:2006
-
负责人:CHEMYONG JAY KO
-
依托单位:
Endothelin-2 in Ovarian Follicle Rupture
-
批准号:7393644
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2006
-
负责人:CHEMYONG JAY KO
-
依托单位:
Mechanism of Periovulatory Leukocyte Infiltration into the Ovary
-
批准号:8609429
-
项目类别:
-
资助金额:$13.65万
-
财政年份:--
-
负责人:CHEMYONG JAY KO
-
依托单位:
Mechanism of Periovulatory Leukocyte Infiltration into the Ovary
-
批准号:9117287
-
项目类别:
-
资助金额:$12.28万
-
财政年份:--
-
负责人:CHEMYONG JAY KO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: